Le Lézard
Classified in: Health
Subject: MAT

ALLURE GLOBAL IS EXPANDING INTO SOUTH AMERICA: Allure Global is a certified partner of the Brazilian Health Regulatory Agency (Anvisa)


Allure Global has gained Anvisa authorization to sell their products in Brazil

LOS ANGELES, Nov. 21, 2023 /PRNewswire-PRWeb/ -- As of October 12th, 2023, Allure Global has been approved and cleared by Anvisa, the Brazilian Health Regulatory Agency to sell CBD products in Brazil. "We are proud to continue our international expansion and bring our collection of health and wellness CBD products to Brazil," said President & CEO, Sandro Costa. "We believe our experience and leadership in the health and wellness CBD market can be leveraged to develop strong relationships and further unlock opportunities in South America."

"We believe our experience and leadership in the health and wellness CBD market can be leveraged to develop strong relationships and further unlock opportunities in South America."

Allure Global has secured partnership agreements with multiple specialized sales distribution networks to effectively reach the medical industry with an extensive line of products. Allure Global uses a holistic approach to symptom-based solutions to give customers an experience of relief they deserve. The product line is unique and has a wide range of applications to aid various ailments. The focal points for improving overall health include a sleep aid, award winning sleep gummies, improving daily life and managing stress levels, vitality cbd oil, improving facial skin, daily moisturizer, a revitalizing retinol night cream, facial sheet mask, sexual aid for menopausal women, intimacy lubricant and providing pain relief with cbd infused topical cream, relief oil .

Innovation is key:

The business model and purpose of Allure Global is to revolutionize and lead the CBD health and wellness industry. Allure Global is a US based company that specializes in the research and development of cannabidiol derivatives while being a principal leader in the import and export market for CBD.

Join the revolution, choose Allure Global, and find your balance!

Media Contact

Bianca Alvarado, Allure Global, 1 818-208-4582, [email protected], https://allure-global.com/

Sandro Costa, President and CEO, Allure Global, [email protected], https://allure-global.com/

SOURCE Allure Global


These press releases may also interest you

at 11:55
The Melanoma Research Foundation to host the DC Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K...

at 11:30
NAMIWalks Greater LA County Mental Health Festival Taking Place at LA State Historic Park
The National Alliance on Mental Illness Greater L.A. County (NAMI GLAC) will celebrate its 20th annual NAMIWalks Greater LA County Mental Health Festival during Mental Health Awareness Month on Saturday, May 4, 2024. This free community wide event at...

at 10:30
Flourishing Foundations Recovery Opens New Outpatient Drug and Alcohol Detox Facility in San Antonio, TX
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue becomes the only company in its sector in Quebec to receive international ISO-45001 health & safety recertification
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

More news about Health...


News published on and distributed by: